Engineering fusogenic molecules to achieve targeted transduction of enveloped lentiviral vectors

Journal of Biological Engineering

Volumn 3, Issue , 2009, Pages

  Lei, Yuning ^a   Joo, Kye Il ^a   Wang, Pin ^a  

^a University of Southern California ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; LENTIVIRUS VECTOR; VIRUS GLYCOPROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE MUTATION; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LYMPHOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PH; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN ENGINEERING; PROTEIN MODIFICATION; TARGET CELL; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

SINDBIS VIRUS;

EID: 67749122646     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1186/1754-1611-3-8     Document Type: Article

References (41)

1. Verma IM Somia N Gene therapy - promises, problems and prospects Nature 1997, 389:239-242. 10.1038/38410 9305836
2. Breckpot K Aerts JL Thielemans K Lentiviral vectors for cancer immunotherapy: Transforming infectious particles into therapeutics Gene Ther 2007, 14:847-862. 10.1038/sj.gt.3302947 17361214
3. Waehler R Russell SJ Curiel DT Engineering targeted viral vectors for gene therapy Nat Rev Genet 2007, 8:573-587. 10.1038/nrg2141 17607305
4. Sandrin V Russell SJ Cosset FL Targeting retroviral and lentiviral vectors Curr Top Microbio Immunol 2003, 281:137-178.
5. Ager S Nilson BH Morling FJ Peng KW Cosset FL Russell SJ Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity Hum Gene Ther 1996, 7:2157-2164. 10.1089/ hum.1996.7.17-2157 8934229
6. Han X Kasahara N Kan YW Ligand-directed retroviral targeting of human breast cancer cells Proc Natl Acad Sci USA 1995, 92:9747-9751. 40879 7568210 10.1073/pnas.92.21.9747
7. Kasahara N Dozy AM Kan YW Tissue-specific targeting of retroviral vectors through ligand-receptor interactions Science 1994, 266:1373-1376. 10.1126/science.7973726 7973726
8. Marin M Noel D Valsesia-Wittman S Brockly F Etienne-Julan M Russell S Cosset FL Piechaczyk M Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins J Virol 1996, 70:2957-2962. 190154 8627771
9. Nilson BH Morling FJ Cosset FL Russell SJ Targeting of retroviral vectors through protease-substrate interactions Gene Ther 1996, 3:280-286. 8732159
10. Somia NV Zoppe M Verma IM Generation of targeted retroviral vectors by using single-chain variable fragment: An approach to in vivo gene delivery Proc Natl Acad Sci USA 1995, 92:7570-7574. 41381 7638232 10.1073/pnas.92.16.7570
11. Chowdhury S Chester KA Bridgewater J Collins MK Martin F Efficient retroviral vector targeting of carcinoembryonic antigen-positive tumors Mol Ther 2004, 9:85-92. 10.1016/j.ymthe.2003.10.004 14741781
12. Boerger AL Snitkovsky S Young JA Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types Proc Natl Acad Sci USA 1999, 96:9867-9872. 22302 10449786 10.1073/ pnas.96.17.9867
13. Morizono K Bristol G Xie YM Kung SK Chen IS Antibody-directed targeting of retroviral vectors via cell surface antigens J Virol 2001, 75:8016-8020. 115045 11483746 10.1128/JVI.75.17.8016-8020.2001
14. Morizono K Xie Y Ringpis GE Johnson M Nassanian H Lee B Wu L Chen IS Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection Nat Med 2005, 11:346-352. 10.1038/nm1192 15711560
15. Morizono K Ringpis GE Pariente N Xie Y Chen IS Transient low pH treatment enhances infection of lentiviral vector pseudotypes with a targeting Sindbis envelope Virology 2006, 355:71-81. 10.1016/ j.virol.2006.07.015 16905172
16. Pariente N Morizono K Virk MS Petrigliano FA Reiter RE Lieberman JR Chen IS A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration Mol Ther 2007, 15:1973-1981. 10.1038/sj.mt.6300271 17653099
17. Roux P Jeanteur P Piechaczyk M A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses Proc Natl Acad Sci USA 1989, 86:9079-9083. 298437 2556698 10.1073/pnas.86.23.9079
18. Pariente N Mao SH Morizono K Chen IS Efficient targeted transduction of primary human endothelial cells with dual-targeted lentiviral vectors J Gene Med 2008, 10:242-248. 10.1002/jgm.1151 18074400
19. Lavillette D Russell SJ Cosset FL Retargeting gene delivery using surface-engineered retroviral vector particles Curr Opin Biotech 2001, 12:461-466. 10.1016/S0958-1669(00)00246-9 11604321
20. Kohn DB Lentiviral vectors ready for prime-time Nat Biotechnol 2007, 25:65-66. 10.1038/nbt0107-65 17211402
21. Yang L Bailey L Baltimore D Wang P Targeting lentiviral vectors to specific cell types in vivo Proc Natl Acad Sci USA 2006, 103:11479-11484. 1518805 16864770 10.1073/pnas.0604993103
22. Joo KI Wang P Visualization of targeted transduction by engineered lentiviral vectors Gene ther 2008, 15:1384-1396. 2575058 18480844 10.1038/gt.2008.87
23. Lu YE Cassese T Kielian M The cholesterol requirement for sindbis virus entry and exit and characterization of a spike protein region involved in cholesterol dependence J Virol 1999, 73:4272-4278. 104207 10196324
24. Stashenko P Nadler LM Hardy R Schlossman SF Characterization of a human B lymphocyte-specific antigen J Immunol 1980, 125:1678-1685. 6157744
25. Anderson KC Bates MP Slaughenhoupt BL Pinkus GS Schlossman SF Nadler LM Expression of human B cell-associated antigens on leukemias and lymphomas: A model of human B cell differentiation Blood 1984, 63:1424-1433. 6609729
26. Reff ME Carner K Chambers KS Chinn PC Leonard JE Raab R Newman RA Hanna N Anderson DR Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20 Blood 1994, 83:435-445. 7506951
27. Molina A A decade of rituximab: Improving survival outcomes in non-Hodgkin's lymphoma Annu Rev Med 2008, 59:237-250. 10.1146/ annurev.med.59.060906.220345 18186705
28. Mukhopadhyay S Kuhn RJ Rossmann MG A structural perspective of the flavivirus life cycle Nat Rev Microbiol 2005, 3:13-22. 10.1038/ nrmicro1067 15608696
29. Pear WS Nolan GP Scott ML Baltimore D Production of high-titer helper-free retroviruses by transient transfection Proc Natl Acad Sci USA 1993, 90:8392-8396. 47362 7690960 10.1073/pnas.90.18.8392
30. Lois C Hong EJ Pease S Brown EJ Baltimore D Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors Science 2002, 295:868-872. 10.1126/science.1067081 11786607
31. Cronin J Zhang XY Reiser J Altering the tropism of lentiviral vectors through pseudotyping Curr Gene Ther 2005, 5:387-398. 1368960 16101513 10.2174/1566523054546224
32. McDonald D Vodicka MA Lucero G Svitkina TM Borisy GG Emerman M Hope TJ Visualization of the intracellular behavior of HIV in living cells J Cell Biol. 2002, 159(3):441-452. 10.1083/jcb.200203150 12417576 2173076
33. Darrah PA Patel DT De Luca PM Lindsay RWB Davey DF Flynn BJ Hof ST Andersen P Reed SG Morris SL Roederer M Seder RA Multifunctional Th1 cells define a correlate of vaccine mediated protection against Leishmania major Nat Med 2007, 13:843-850. 10.1038/nm1592 17558415
34. Mellman I Fuchs R Helenius A Acidification of the endocytic and exocytic pathways Annu Rev Biochem 1986, 55:663-700. 10.1146/ annurev.bi.55.070186.003311 2874766
35. Serafini M Naldini L Introna M Molecular evidece of inefficient transduction of proliferating human B lymphocytes by VSV-pseudotyped HIV-1-derived lentivectors Virology 2004, 325:413-424. 10.1016/ j.virol.2004.04.038 15246279
36. Kielian M Rey FA Virus membrane-fusion proteins: More than one way to make a hairpin Nat Rev Microbiol 2005, 4:67-76. 10.1038/nrmicro1326
37. Daniels RS Downie JC Hay AJ Knossow M Skehel JJ Wang ML Wiley DC Fusion mutants of the influenza virus hemagglutinin glycoprotein Cell 1985, 40:431-439. 10.1016/0092-8674(85)90157-6 3967299
38. Ziegler L Yang L Joo K Yang H Baltimore D Wang P Targeting Lentiviral Vectors to Antigen-Specific Immunoglobulins Hum Gene Ther 2008, 19:861-872. 2599792 18590376 10.1089/hum.2007.149
39. Yang H Zeigler L Joo K Cho T Lei Y Wang P Gamma-Retroviral Vectors Enveloped With an Antibody and an Engineered Fusogenic Protein Achieved Antigen-Specific Targeting Biotechnol Bioeng 2008, 101:357-368. 2561946 18435481 10.1002/bit.21903
40. Burton DR Pyati J Koduri R Sharp SJ Thornton GB Parren PW Sawyer LS Hendry RM Dunlop N Nara PL Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody Science 1994, 266:1024-1027. 10.1126/science.7973652 7973652
41. Klages N Zufferey R Trono D A stable system for the high-titer production of multiply attenuated lentiviral vectors Mol Ther 2000, 2:170-176. 10.1006/mthe.2000.0103 10947945